Get my own profile
Public access
View all23 articles
1 article
available
not available
Based on funding mandates
Co-authors
Peter GoosKU LeuvenVerified email at biw.kuleuven.be
Martina VandebroekKU LeuvenVerified email at kuleuven.be
Philippe BeutelsProfessor at Vaccine & Infectious Disease Institute, University of Antwerp, BelgiumVerified email at uantwerpen.be
Bradley JonesSAS InstituteVerified email at sas.com
Guido ErreygersProfessor of Economics, University of AntwerpVerified email at uantwerpen.be
Ann VerhetselProfessor of Economic Geography, University of AntwerpVerified email at uantwerpen.be
Lander WillemCenter for Health Economics Research and Modeling of Infectious Diseases, University of AntwerpVerified email at uantwerpen.be
Frederik VerelstAssociate Director, Vaccines Value Evidence / Health Outcomes, GlaxoSmithKlineVerified email at gsk.com
G. Ardine de WitUniversity Medical Centre Utrecht & National Institute of Public Health, the NetherlandsVerified email at rivm.nl
Sandy TubeufUniversité Catholique de LouvainVerified email at uclouvain.be
Eddy Van de VoordeUniversiteit AntwerpenVerified email at uantwerpen.be
Niek MouterAssociate professor Delft University of TechnologyVerified email at tudelft.nl
Toon ZijlstraSenior ResearcherVerified email at minienw.nl
Albert Jan van HoekHealth economist / Infectious disease modeller, RIVMVerified email at rivm.nl
Maarten van WijhePost-doctoral fellow, University of RoskildeVerified email at ruc.dk
Job van ExelErasmus University RotterdamVerified email at eshpm.eur.nl
Daniel Palhazi CuervoSINTEF DigitalVerified email at sintef.no
Frank WitloxSenior Full Professor of Economic Geography at Ghent UniversityVerified email at ugent.be
Veronique Van AckerLuxembourg Institute of Socio-Economic Research (LISER)Verified email at liser.lu
sermeus walterprofessor, Catholic University LeuvenVerified email at med.kuleuven.be